Marijuana Doctors's Direct-to-Consumer Weed
A milestone of sorts took place on Monday March 3 when MarijuanaDoctors.com began airing a television commercial that looks to be the first ever marijuana commercial on a major TV network.
A milestone of sorts took place on Monday March 3 when MarijuanaDoctors.com began airing a television commercial that looks to be the first ever marijuana commercial on a major TV network. The spot began airing in New Jersey and is believed to be the first time that any major television network in the U.S. has allowed a commercial addressing the controversial subject matter and advertising the first ever medical marijuana service.
Major networks under the umbrella of Comcast - FOX, Food Network, and Bravo FX etc - have given the commercial the green light.
It wasn’t an easy launch: “Securing the airtime for our commercial on a major network was extremely difficult and at the same time, extremely satisfying,” stated Jason Draizin, Founder and CEO of MarijuanaDoctors.com, Inc.
He added: “The goal of MarijuanaDoctors.com is to bridge that gap between the patients who have a need for marijuana recommendations, and the doctors who write medical marijuana recommendations.” The company allows patients to fill out a form on their website to find a certified physician near their location.
The curious comparison in the commercial has a shady street dealer trying to push tainted sushi on an unsuspecting buyer and medical marijuana patients similarly forced to obtain their weed from the street. Hard to make the leap between an off-tuna roll (or that there even is such a thing as a sushi dealer) and bad pot, but the parallel was drawn in an attempt to prove the severity of consulting physicians in order to obtain medical marijuana for terminal and debilitating medical conditions, rather than reporting to illegal means.
“We felt the viewing public would agree that in the states providing safe access, continuing to obtain medicine illegally is as absurd as purchasing raw fish from a drug dealer,” concluded Draizin.
Addressing Disparities in Psoriasis Trials: Takeda's Strategies for Inclusivity in Clinical Research
April 14th 2025LaShell Robinson, Head of Global Feasibility and Trial Equity at Takeda, speaks about the company's strategies to engage patients in underrepresented populations in its phase III psoriasis trials.
Beyond the Prescription: Pharma's Role in Digital Health Conversations
April 1st 2025Join us for an insightful conversation with Jennifer Harakal, Head of Regulatory Affairs at Canopy Life Sciences, as we unpack the evolving intersection of social media and healthcare decisions. Discover how pharmaceutical companies can navigate regulatory challenges while meaningfully engaging with consumers in digital spaces. Jennifer shares expert strategies for responsible marketing, working with influencers, and creating educational content that bridges the gap between patients and healthcare providers. A must-listen for pharma marketers looking to build trust and compliance in today's social media landscape.
